# Pharmacokinetics and Bioavailability Study of Lasolvan Hard Capsules and Effervescent Tablets in Healthy Volunteers

> **NCT02036775** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lasolvan tablet
- **DRUG:** Lasolvan tablet
- **DRUG:** Lasolvan tablet
- **DRUG:** Lasolvan tablet
- **DRUG:** Lasolvan effervescent tablet
- **DRUG:** Lasolvan effervescent tablet
- **DRUG:** Lasolvan effervescent tablet
- **DRUG:** Lasolvan prolonged-release hard capsule
- **DRUG:** Lasolvan prolonged-release hard capsule
- **DRUG:** Lasolvan prolonged-released capsules
- **DRUG:** Lasolvan tablet
- **DRUG:** Lasolvan tablet
- **DRUG:** Lasolvan prolonged-release hard capsule
- **DRUG:** Lasolvan effervescent tablet
- **DRUG:** Lasolvan prolonged-release hard capsule
- **DRUG:** Lasolvan prolonged-release hard capsule
- **DRUG:** Lasolvan effervescent tablet
- **DRUG:** Lasolvan effervescent tablet

## Key facts

- **NCT ID:** NCT02036775
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036775, "Pharmacokinetics and Bioavailability Study of Lasolvan Hard Capsules and Effervescent Tablets in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02036775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*